SLNO - Soleno Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$80.00
DETAILS
HIGH:
$107.00
LOW:
$53.00
MEDIAN:
$80.00
CONSENSUS:
$80.00
UPSIDE:
50.91%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 190.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1,553.0) | 1.5 | 0.4 | 0 | 3 | 0 |
| Cost of Revenue | 2.7 | 0 | 0 | 0 | 0 | 2.2 | 2.3 | 1.9 | 1.6 | 1.5 | 0.4 | 0 | 0 | 0 |
| Gross Profit | 187.7 | 0 | 0 | 0 | 0 | (2.2) | (2.3) | (1.9) | (1,554.6) | (0.1) | 0.0 | 0 | 3 | 0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 40.6 | 78.6 | 25.2 | 15.3 | 21.5 | 23.2 | 16.3 | 7.2 | 3.1 | 5.2 | 4.5 | 2.2 | 2.4 | 2.5 |
| SG&A Expenses | 132.1 | 105.9 | 13.5 | 9.8 | 10.8 | 6.6 | 4.6 | 6.6 | 6.6 | 8.4 | 7.9 | 2.9 | 1.5 | 1.1 |
| Other Expenses | 0 | 3.2 | 2.7 | (0.7) | (0.7) | 0 | 0 | 0.0 | (0.6) | (0.1) | (0.2) | 0 | (0.0) | (0.0) |
| Operating Expenses | 172.8 | 187.7 | 41.4 | 24.4 | 31.5 | 29.8 | 20.9 | 13.7 | 9.7 | 13.6 | 12.2 | 5.2 | 3.8 | 3.6 |
| Operating Income | ||||||||||||||
| Operating Income | 14.9 | (187.7) | (41.4) | (24.4) | (31.5) | (31.9) | (23.2) | (14.3) | (12.2) | (13.6) | (12.2) | (5.2) | (0.8) | (3.6) |
| Interest Expense | 5.5 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 3.0 | 4.1 | 2.9 | 2.9 |
| Interest Income | 17.0 | 12.1 | 2.6 | 0.3 | 0.1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 |
| Profitability | ||||||||||||||
| EBITDA | 28.4 | (173.6) | (37.0) | (22.1) | (30.3) | (22.4) | (28.5) | (9.9) | (8.1) | (6.7) | (15.8) | (5.1) | (0.8) | (3.6) |
| EBIT | 26.4 | (175.6) | (39.0) | (24.1) | (32.3) | (24.6) | (30.8) | (13.7) | (13.4) | (6.7) | (12.2) | (9.7) | (0.8) | (3.6) |
| Income Before Tax | 20.9 | (175.8) | (39.0) | (24.1) | (30.9) | (24.6) | (30.8) | (11.8) | (13.7) | (12.0) | (15.9) | (13.9) | (3.7) | (6.5) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.7) | 0.0 | 0 | (0.5) | 0 | 0 |
| Net Income | 20.9 | (175.8) | (39.0) | (24.1) | (30.9) | (24.6) | (30.8) | (13.3) | (15.7) | (12.1) | (15.9) | (13.9) | (3.7) | (6.5) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | 0.41 | -4.38 | -2.36 | -2.87 | -5.81 | -3.68 | -15.78 | -9.54 | -26.18 | -58.35 | -126.58 | -819.38 | -198.45 | -346.98 |
| EPS (Diluted) | 0.39 | -4.38 | -2.36 | -2.87 | -5.81 | -3.68 | -15.78 | -9.54 | -26.18 | -58.35 | -126.58 | -819.38 | -198.45 | -346.98 |
| Shares Outstanding | 53.2 | 40.2 | 16.5 | 8.4 | 5.3 | 4.2 | 2.3 | 1.4 | 0.6 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 70.1 | 87.9 | 169.7 | 14.6 | 21.3 | 49.2 | 20.7 | 23.1 | 17.1 | 2.7 |
| Short-Term Investments | 235.4 | 203.5 | 0 | 0 | 0 | 0 | 0 | 1.0 | 0 | 0 |
| Net Receivables | 28.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 |
| Inventory | 15.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.7 |
| Other Current Assets | 7.1 | 2.5 | 1.7 | 1.0 | 0 | 0 | 0 | 0 | 0.6 | 0.7 |
| Total Current Assets | 355.8 | 293.9 | 171.4 | 15.6 | 22.4 | 50.2 | 21.1 | 24.7 | 18.0 | 3.8 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 2.4 | 3.0 | 0.4 | 0.2 | 0.5 | 0.2 | 0.4 | 0.0 | 0.0 | 0.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.7 |
| Intangible Assets | 4.9 | 6.8 | 8.7 | 10.7 | 12.6 | 14.6 | 16.5 | 18.5 | 20.4 | 0.8 |
| Long-Term Investments | 0 | 27.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 200.8 | 0.1 | 0.2 | 0 | 0.0 | 0 | 0.1 | 0 | 0.6 | 0.1 |
| Total Non-Current Assets | 208.0 | 37.1 | 9.3 | 10.8 | 13.1 | 14.7 | 17.0 | 18.5 | 21.0 | 1.8 |
| Total Assets | 563.8 | 331.0 | 180.7 | 26.5 | 35.6 | 65.0 | 38.2 | 43.2 | 39.0 | 5.6 |
| Current Liabilities | ||||||||||
| Account Payables | 12.4 | 8.9 | 3.1 | 1.8 | 3.3 | 3.5 | 2.0 | 0.9 | 0.6 | 0.4 |
| Short-Term Debt | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 48.2 | 9.3 | 4.9 | 2.2 | 1.1 | 1.2 | 0.7 | 0.6 | 0.1 | 0.2 |
| Total Current Liabilities | 61.4 | 18.7 | 11.5 | 7.3 | 8.0 | 8.6 | 5.0 | 1.9 | 1.7 | 1.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 2.0 | 49.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 50.4 | 14.8 | 11.5 | 8.8 | 9.6 | 10.8 | 18.3 | 10.9 | 10.5 | 0.4 |
| Total Non-Current Liabilities | 52.4 | 67.1 | 11.7 | 8.8 | 9.8 | 10.8 | 18.3 | 10.9 | 10.8 | 0.4 |
| Total Liabilities | 113.7 | 85.9 | 23.2 | 16.1 | 17.8 | 19.4 | 23.2 | 12.7 | 12.5 | 2.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (431.4) | (452.3) | (276.4) | (237.4) | (213.4) | (182.4) | (157.8) | (127.0) | (114.0) | (98.3) |
| Accumulated Other Comprehensive Income | 0.4 | 0.4 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.1) | (0.2) |
| Total Stockholders' Equity | 450.1 | 245.1 | 157.5 | 10.3 | 17.8 | 45.5 | 14.9 | 30.4 | 26.5 | 3.4 |
| Total Liabilities & Equity | 563.8 | 331.0 | 180.7 | 26.5 | 35.6 | 65.0 | 38.2 | 43.2 | 39.0 | 5.6 |
| Debt Metrics | ||||||||||
| Total Debt | 2.7 | 52.8 | 0.4 | 0.2 | 0.5 | 0.1 | 0.3 | 0 | 0 | 0 |
| Net Debt | (67.4) | (35.1) | (169.3) | (14.4) | (20.8) | (49.1) | (20.4) | (23.1) | (17.1) | (2.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 20.9 | (175.8) | (39.0) | (24.1) | (30.9) | (24.6) | (30.8) | (11.8) | (12.1) | (12.1) |
| Depreciation & Amortization | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 1.6 | 0.1 |
| Stock-Based Compensation | 45.8 | 100.0 | 5.9 | 2.5 | 3.3 | 1.5 | 0.8 | 1.0 | 0.9 | 0.9 |
| Change in Working Capital | (24.6) | 6.0 | 2.9 | (0.8) | (1.1) | 3.0 | 2.5 | 0.1 | (0.0) | (0.8) |
| Other Non-Cash Items | 2.7 | (1.2) | 3.2 | (0.5) | (1.0) | 4.6 | 1.2 | 1.0 | 1.3 | (1.6) |
| Operating Cash Flow | 46.8 | (69.1) | (24.9) | (20.8) | (27.8) | (25.2) | (17.4) | (11.7) | (9.9) | (13.5) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.1) | (0.2) | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | (0.6) | 0 |
| Purchases of Investments | (455.8) | (356.5) | 0 | 0 | 0 | 0 | (0.5) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 254.1 | 131 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | (0.2) | 1.0 | (0.0) |
| Investing Cash Flow | (201.8) | (225.7) | 0 | (0.0) | (0.0) | (0.0) | 0.5 | (0.2) | 0.4 | (0.0) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 49.9 | 0 | 0 | (0.0) | (0.0) | (0.0) | 0 | 0 | 0 |
| Stock Repurchased | (100.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (7.8) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.8) | 14.2 | 42.2 | (0.0) | (0.1) | 0.0 | 0 | 1.5 | (0.8) | (0.0) |
| Financing Cash Flow | 137.2 | 213.0 | 180.0 | 14.1 | (0.1) | 53.7 | 14.5 | 17.8 | 23.9 | 10.8 |
| Cash Position | ||||||||||
| Net Change in Cash | (17.8) | (81.8) | 155.1 | (6.7) | (27.9) | 28.5 | (2.4) | 6.0 | 14.4 | (2.8) |
| Cash at Beginning | 87.9 | 169.7 | 14.6 | 21.3 | 49.2 | 20.7 | 23.1 | 17.1 | 2.7 | 5.5 |
| Cash at End | 70.1 | 87.9 | 169.7 | 14.6 | 21.3 | 49.2 | 20.7 | 23.1 | 17.1 | 2.7 |
| Free Cash Flow | 46.7 | (69.3) | (24.9) | (20.8) | (27.8) | (25.2) | (17.4) | (11.7) | (10.0) | (13.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 190.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1,553.0) | 1.5 | 0.4 | 0 | 3 | 0 |
| Gross Profit | 187.7 | 0 | 0 | 0 | 0 | (2.2) | (2.3) | (1.9) | (1,554.6) | (0.1) | 0.0 | 0 | 3 | 0 |
| Operating Income | 14.9 | (187.7) | (41.4) | (24.4) | (31.5) | (31.9) | (23.2) | (14.3) | (12.2) | (13.6) | (12.2) | (5.2) | (0.8) | (3.6) |
| Net Income | 20.9 | (175.8) | (39.0) | (24.1) | (30.9) | (24.6) | (30.8) | (13.3) | (15.7) | (12.1) | (15.9) | (13.9) | (3.7) | (6.5) |
| EPS (Diluted) | 0.39 | -4.38 | -2.36 | -2.87 | -5.81 | -3.68 | -15.78 | -9.54 | -26.18 | -58.35 | -126.58 | -819.38 | -198.45 | -346.98 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 70.1 | 87.9 | 169.7 | 14.6 | 21.3 | 49.2 | 20.7 | 23.1 | 17.1 | 2.7 | ||||
| Total Assets | 563.8 | 331.0 | 180.7 | 26.5 | 35.6 | 65.0 | 38.2 | 43.2 | 39.0 | 5.6 | ||||
| Total Debt | 2.7 | 52.8 | 0.4 | 0.2 | 0.5 | 0.1 | 0.3 | 0 | 0 | 0 | ||||
| Stockholders' Equity | 450.1 | 245.1 | 157.5 | 10.3 | 17.8 | 45.5 | 14.9 | 30.4 | 26.5 | 3.4 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | 46.8 | (69.1) | (24.9) | (20.8) | (27.8) | (25.2) | (17.4) | (11.7) | (9.9) | (13.5) | ||||
| Capital Expenditure | (0.1) | (0.2) | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | ||||
| Free Cash Flow | 46.7 | (69.3) | (24.9) | (20.8) | (27.8) | (25.2) | (17.4) | (11.7) | (10.0) | (13.5) | ||||